Table 2.
Variables | Before PS Matching | After PS Matching | ||||
---|---|---|---|---|---|---|
OLR (n = 160) | LLR (n = 96) | p-Value | OLR (n = 91) | LLR (n = 91) | p-Value | |
ASA classification | 0.949 | 0.648 | ||||
1 | 10 (6.3%) | 3 (3.1%) | 3 (3.3%) | 2 (2.2%) | ||
2 | 134 (83.8%) | 86 (89.6%) | 78 (85.7%) | 82 (90.1%) | ||
3 | 16 (10.0%) | 7 (7.3%) | 10 (11.0%) | 7 (7.7%) | ||
Previous abdominal operation | 42 (26.3%) | 18 (18.8%) | 0.223 | 23 (25.3%) | 16 (17.6%) | 0.278 |
Extent of resection (major) | 79 (49.4%) | 46 (48.4%) | 0.898 | 40 (44.0%) | 44 (48.9%) | 0.552 |
Operation time (min) | 222 (71–599) | 239 (43–590) | 0.345 | 204 (71–408) | 240 (43–590) | 0.040 |
Blood loss during operation (mL) | 300 (30–3000) | 250 (30–2500) | 0.750 | 200 (50–1500) | 250 (50–2500) | 0.172 |
RBC transfusion during operation | 10 (6.3%) | 4 (4.2%) | 0.579 | 1 (1.1%) | 4 (4.4%) | 0.368 |
Tumor size (cm) | 3.9 (0.3–17.0) | 2.6 (0.9–14.0) | <0.001 | 2.9 (0.3–13.2) | 2.6 (0.9–14.0) | 0.445 |
Tumor size > 10 cm | 12 (7.5%) | 4 (4.2%) | 0.425 | 3 (3.3%) | 4 (4.4%) | 0.700 |
Tumor grade 3 or 4 | 21 (13.3%) | 5 (5.2%) | 0.053 | 11 (12.4%) | 4 (4.4%) | 0.063 |
Tumor necrosis | 67 (43.5%) | 35 (38.0%) | 0.425 | 33 (37.9%) | 34 (39.1%) | 0.876 |
Complete encapsulation | 121 (77.6%) | 68 (70.8%) | 0.189 | 63 (72.4%) | 64 (70.3%) | 0.843 |
Microvascular invasion | 110 (68.8%) | 58 (60.4%) | 0.178 | 51 (56.0%) | 58 (63.7%) | 0.364 |
Portal vein tumor thrombosis | 5 (3.1%) | 7 (7.3%) | 0.139 | 0 (0%) | 7 (7.7%) | 0.014 |
Intrahepatic metastasis | 6 (3.8%) | 2 (2.1%) | 0.714 | 3 (3.3%) | 2 (2.2%) | 0.650 |
Cirrhosis | 50 (31.3%) | 46 (47.9%) | 0.011 | 40 (44.0%) | 43 (47.3%) | 0.766 |
Free resection margin (mm) | 10 (2–55) | 10 (2–65) | 0.428 | 10 (2–55) | 10 (2–65) | 0.865 |
Hospitalization (day) | 10 (5–177) | 7 (4–41) | <0.001 | 9 (5–177) | 7 (4–41) | <0.001 |
PS, propensity score; OLR, open liver resection; LLR, laparoscopic liver resection; ASA, American Standards Association; RBC, red blood cell.